Your browser doesn't support javascript.
loading
Co-treatment of Low Dose Pacritinib, a Phase III Jak2 Inhibitor, Greatly Increases Apoptosis of P-gp Over-expressing Cancer Cells With Multidrug Resistance.
Oh, Yunmoon; Lee, Jin-Sol; Lee, Ji Sun; Park, Jae Hyeon; Kim, Hyung Sik; Yoon, Sungpil.
Affiliation
  • Oh Y; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Lee JS; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Lee JS; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Park JH; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Kim HS; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea.
  • Yoon S; School of Pharmacy, Sungkyunkwan University, Suwon, Republic of Korea syoon88@gmail.com.
Anticancer Res ; 42(5): 2433-2442, 2022 May.
Article in En | MEDLINE | ID: mdl-35489775
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ATP Binding Cassette Transporter, Subfamily B, Member 1 / Neoplasms Limits: Humans Language: En Journal: Anticancer Res Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: ATP Binding Cassette Transporter, Subfamily B, Member 1 / Neoplasms Limits: Humans Language: En Journal: Anticancer Res Year: 2022 Document type: Article